Alibaba Health, Sinovac in deal to build platform for COVID-19 vaccine inoculation

Alibaba Health, Sinovac in deal to build platform for COVID-19 vaccine inoculation

FILE PHOTO: Booth displaying coronavirus vaccine candidate from Sinovac Biotech Ltd in Beijing
A booth displaying a COVID-19 vaccine candidate from Sinovac Biotech is seen at the 2020 China International Fair for Trade in Services (CIFTIS) in Beijing, China on Sep 4, 2020. (Photo: ReutersTingshu Wang/File Photo) 

BEIJING: Alibaba Health Information Technology said on Thursday (Sep 17) it has signed a strategic cooperation agreement with Chinese COVID-19 vaccine developer Sinovac Biotech.

The two firms will jointly build a platform for coronavirus vaccine inoculation in the future, Alibaba Health said in Chinese social media platform Weibo, without giving further details.

READ: China's Sinovac to test coronavirus vaccine candidate in teenagers, children 

Sinovac's coronavirus vaccine candidate CoronaVac, being tested in final-stage large-scale trials in Brazil, Indonesia and Turkey, has already been given to tens of thousands of people via an emergency use programme China launched in July.

They include around 90 per cent of the firm's employees and their families.

The two firms will also cooperate in broader areas including online booking of vaccines and post-vaccination health condition follow-up, Alibaba Health said. 

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters/ad

Bookmark